TLSA Tiziana Life Sciences, Ltd.: Net earnings per share for the last 12 months

Tiziana Life Sciences (TLSA) ensures global antibody transportation with strict temperature control, minimizing customs risks to preserve profits. This EPS price chart reflects -79.50, which correlates with the development of targeted therapies for multiple sclerosis and Crohn's disease. Production stability is maintained through GMP contractors and precise scheduling of laboratory box operations.
Financial and market metric breakdowns for Tiziana Life Sciences PLC (TLSA)

For the biotech startup Tiziana Life Sciences (TLSA), the EPS YoY TTM growth efficiency indicator reflects the annual dynamics of earnings per share. This metric compares the current twelve-month result with the same period last year to identify business scaling rates. The curve's high sensitivity to immune research expenses exposes a critical level of capital burn. Sharp fluctuations in the indicator signal a risk of asset revaluation amid a cash deficit.